"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 86 | 86 |
| 1995 | 0 | 135 | 135 |
| 1996 | 0 | 139 | 139 |
| 1997 | 1 | 141 | 142 |
| 1998 | 0 | 153 | 153 |
| 1999 | 0 | 172 | 172 |
| 2000 | 0 | 177 | 177 |
| 2001 | 1 | 224 | 225 |
| 2002 | 0 | 303 | 303 |
| 2003 | 0 | 345 | 345 |
| 2004 | 1 | 338 | 339 |
| 2005 | 0 | 402 | 402 |
| 2006 | 0 | 444 | 444 |
| 2007 | 0 | 446 | 446 |
| 2008 | 0 | 508 | 508 |
| 2009 | 0 | 503 | 503 |
| 2010 | 0 | 582 | 582 |
| 2011 | 0 | 663 | 663 |
| 2012 | 0 | 693 | 693 |
| 2013 | 0 | 703 | 703 |
| 2014 | 0 | 726 | 726 |
| 2015 | 1 | 762 | 763 |
| 2016 | 0 | 711 | 711 |
| 2017 | 0 | 727 | 727 |
| 2018 | 0 | 739 | 739 |
| 2019 | 0 | 683 | 683 |
| 2020 | 0 | 598 | 598 |
| 2021 | 0 | 452 | 452 |
| 2022 | 0 | 95 | 95 |
| 2023 | 0 | 83 | 83 |
| 2024 | 0 | 336 | 336 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
The IL-1? inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial. Nat Commun. 2024 Nov 13; 15(1):9840.
-
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precis Oncol. 2024 Nov; 8:e2400375.
-
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis. Blood. 2024 Nov 07; 144(19):2063-2066.
-
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study. Emerg Microbes Infect. 2024 Dec; 13(1):2421397.
-
Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer. Int J Gynecol Cancer. 2024 Nov 04; 34(11):1719-1728.
-
Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens: A tertiary cancer center experience. Am J Clin Pathol. 2024 Nov 04; 162(5):492-499.
-
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. Am J Clin Pathol. 2024 Nov 04; 162(5):455-463.
-
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare. Int J Gynecol Cancer. 2024 Nov 04; 34(11):1661-1670.
-
Protein Consumption and Risk of CVD Among U.S. Adults: The Multi-Ethnic Study of Atherosclerosis (MESA). Nutrients. 2024 Nov 02; 16(21).
-
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial. Target Oncol. 2024 Nov; 19(6):879-892.